ASELAGE STEVE
Insider CIK 1221599 · BMRN EVP, Chief Business Officer · ACER Director · RTRX President and COO, Director · BCRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2024-06-12 | 2024-06-14 | 49,933 | — | $0 | 49,933 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2024-06-12 | 2024-06-14 | 6,820 | — | $0 | 70,159 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2024-05-24 | 2024-05-29 | 2,500 | $6.40 | $16.0K | 2,500 | SEC↗ |
| ACER Acer Therapeutics Inc. | D To issuer | 2023-11-17 | 2023-11-20 | 483,741 | — | $0 | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2023-06-13 | 2023-06-15 | 39,072 | — | $0 | 39,072 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-06-13 | 2023-06-15 | 16,745 | — | $0 | 63,339 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2023-03-14 | 2023-03-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ACER Acer Therapeutics Inc. | P Buy | 2022-11-29 | 2022-12-01 | 409,836 | $1.22 | $500.0K | 483,741 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2022-06-07 | 2022-06-09 | 30,022 | — | $0 | 30,022 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-06-07 | 2022-06-09 | 12,866 | — | $0 | 46,594 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-05-31 | 2022-06-02 | 569 | $9.31 | $5.3K | 33,728 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-05-11 | 2022-05-12 | 2,575 | $21.92 | $56.4K | 146,919 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-02-28 | 2022-03-02 | 301 | $16.61 | $5.0K | 33,159 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2022-01-14 | 2022-01-19 | 18,500 | — | $0 | 18,500 | SEC↗ |
| ACER Acer Therapeutics Inc. | P Buy | 2021-12-10 | 2021-12-13 | 7,984 | $2.04 | $16.3K | 73,905 | SEC↗ |
| ACER Acer Therapeutics Inc. | P Buy | 2021-12-09 | 2021-12-13 | 2,016 | $2.15 | $4.3K | 65,921 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-11-30 | 2021-12-02 | 414 | $12.06 | $5.0K | 32,858 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-11-16 | 2021-11-18 | 31,800 | $29.39 | $934.6K | 149,494 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2021-11-05 | 2021-11-09 | 10,000 | — | $0 | 70,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2021-11-05 | 2021-11-09 | 10,000 | $16.23 | $162.3K | 171,794 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-11-05 | 2021-11-09 | 10,000 | $26.23 | $262.3K | 161,794 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-11-02 | 2021-11-03 | 3,500 | $30.00 | $105.0K | 19,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-11-01 | 2021-11-03 | 5,000 | $29.48 | $147.4K | 23,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2021-10-07 | 2021-10-08 | 60,000 | — | $0 | 80,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-10-07 | 2021-10-08 | 32,000 | $26.26 | $840.3K | 189,794 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2021-10-07 | 2021-10-08 | 60,000 | $16.23 | $973.8K | 249,794 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-10-07 | 2021-10-08 | 28,000 | $26.23 | $734.4K | 221,794 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-08-31 | 2021-09-02 | 314 | $15.92 | $5.0K | 32,444 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | G Gift | 2021-07-16 | 2021-11-03 | 3,000 | — | $0 | 161,794 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | G Gift | 2021-07-16 | 2021-11-03 | 3,000 | — | $0 | 28,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-05-28 | 2021-06-01 | 634 | $15.77 | $10.0K | 32,130 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2021-05-25 | 2021-05-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2021-05-14 | 2021-05-18 | 9,000 | — | $0 | 9,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-05-14 | 2021-05-18 | 3,000 | — | $0 | 189,794 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-05-11 | 2021-05-13 | 2,146 | $19.58 | $42.0K | 186,794 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2021-04-16 | 2021-04-20 | 10,000 | — | $0 | 140,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-04-16 | 2021-04-20 | 10,000 | $26.23 | $262.3K | 188,940 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2021-04-16 | 2021-04-20 | 10,000 | $16.23 | $162.3K | 198,940 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2021-03-17 | 2021-03-19 | 10,000 | — | $0 | 150,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2021-03-17 | 2021-03-19 | 10,000 | $16.23 | $162.3K | 206,667 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-03-17 | 2021-03-19 | 7,727 | $27.56 | $213.0K | 188,940 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-03-17 | 2021-03-19 | 10,000 | $27.35 | $273.5K | 196,667 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2021-02-26 | 2021-03-02 | 927 | $10.78 | $10.0K | 31,496 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2021-02-21 | 2021-02-02 | 25,000 | — | $0 | 275,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | G Gift | 2021-02-04 | 2021-11-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | G Gift | 2021-02-04 | 2021-11-03 | 25,000 | — | $0 | 164,794 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2021-02-02 | 2021-02-02 | 25,000 | $10.09 | $252.3K | 221,667 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-02 | 25,000 | $30.75 | $768.8K | 196,667 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2020-12-15 | 2020-12-16 | 5,549 | $26.02 | $144.4K | 196,667 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2020-12-02 | 2020-12-04 | 7,891 | $23.43 | $184.9K | 202,216 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2020-11-30 | 2020-12-02 | 1,956 | $5.11 | $10.0K | 30,569 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | G Gift | 2020-11-19 | 2020-12-04 | 3,000 | — | $0 | 210,107 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-11-06 | 2020-11-06 | 20,625 | $23.00 | $474.4K | 213,107 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-11-05 | 2020-11-06 | 2,500 | $21.26 | $53.2K | 233,732 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2020-08-31 | 2020-09-02 | 2,409 | $4.15 | $10.0K | 28,613 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-08-05 | 2020-08-06 | 2,500 | $19.68 | $49.2K | 236,232 | SEC↗ |
| ACER Acer Therapeutics Inc. | P Buy | 2020-07-24 | 2020-07-28 | 45,000 | $3.50 | $157.5K | 63,905 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-06-25 | 2020-06-29 | 10,000 | $20.00 | $200.0K | 238,732 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2020-06-01 | 2020-06-03 | 1,112 | $4.50 | $5.0K | 26,204 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-05-15 | 2020-05-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-05-15 | 2020-05-19 | 3,000 | — | $0 | 248,732 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-05-14 | 2020-05-14 | 3,062 | $15.09 | $46.2K | 245,732 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-05-13 | 2020-05-14 | 4,063 | $16.41 | $66.7K | 248,794 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2020-05-12 | 2020-05-14 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-05-12 | 2020-05-14 | 1,000 | $17.16 | $17.2K | 252,857 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-05-05 | 2020-05-06 | 2,500 | $15.88 | $39.7K | 253,857 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-03-05 | 2020-03-09 | 4,359 | $15.36 | $67.0K | 256,357 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-03-05 | 2020-03-09 | 12,250 | — | $0 | 260,716 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2020-03-01 | 2020-03-03 | 1,666 | $3.00 | $5.0K | 25,092 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-02-05 | 2020-02-07 | 2,500 | $16.62 | $41.5K | 248,466 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2020-01-02 | 2020-01-03 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2019-12-01 | 2019-12-03 | 1,754 | $2.85 | $5.0K | 23,426 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-11-29 | 2019-11-29 | 5,000 | $13.91 | $69.5K | 250,966 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2019-11-18 | 2019-11-18 | 15,000 | $1.45 | $21.8K | 21,672 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2019-09-01 | 2019-09-04 | 1,672 | $2.99 | $5.0K | 6,672 | SEC↗ |
| ACER Acer Therapeutics Inc. | P Buy | 2019-07-03 | 2019-07-05 | 5,000 | $3.72 | $18.6K | 18,905 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2019-05-29 | 2019-05-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2019-05-22 | 2019-05-24 | 3,000 | $3.57 | $10.7K | 5,000 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-05-15 | 2019-05-16 | 1,838 | $17.82 | $32.8K | 255,966 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-05-14 | 2019-05-16 | 1,838 | $17.79 | $32.7K | 257,804 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 259,642 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | P Buy | 2019-03-12 | 2019-03-14 | 2,000 | $8.30 | $16.6K | 2,000 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-02-12 | 2019-02-13 | 1,065 | $21.50 | $22.9K | 257,642 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2019-02-11 | 2019-02-13 | 1,065 | $21.38 | $22.8K | 258,707 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2019-02-01 | 2019-02-05 | 6,000 | — | $0 | 6,000 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2019-01-04 | 2019-01-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-12-21 | 2018-12-21 | 5,288 | $21.69 | $114.7K | 260,672 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-12-21 | 2018-12-21 | 900 | $22.35 | $20.1K | 259,772 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-12-20 | 2018-12-21 | 6,188 | $21.97 | $136.0K | 265,960 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-12-18 | 2018-12-20 | 20,625 | — | $0 | 272,148 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-12-07 | 2018-12-07 | 10 | $24.04 | $240 | 251,523 | SEC↗ |
| RTRX Retrophin, Inc. | G Gift | 2018-11-29 | 2018-12-07 | 1,750 | — | $0 | 251,533 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-15 | 2018-11-16 | 1,086 | $24.75 | $26.9K | 253,283 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-15 | 2018-11-16 | 4,464 | $24.21 | $108.1K | 254,369 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-14 | 2018-11-16 | 600 | $24.58 | $14.7K | 258,833 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-11-14 | 2018-11-16 | 4,950 | $23.63 | $117.0K | 259,433 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-11-09 | 2018-11-14 | 18,500 | — | $0 | 264,383 | SEC↗ |
| RTRX Retrophin, Inc. | M Exercise deriv | 2018-08-31 | 2018-08-31 | 12,000 | — | $0 | 0 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2018-08-31 | 2018-08-31 | 12,000 | $32.00 | $384.0K | 245,883 | SEC↗ |
| RTRX Retrophin, Inc. | M Exercise | 2018-08-31 | 2018-08-31 | 12,000 | $8.70 | $104.4K | 257,883 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-05-10 | 2018-05-14 | 147,000 | — | $0 | 147,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2018-05-10 | 2018-05-14 | 24,500 | — | $0 | 24,500 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-05-10 | 2018-05-14 | 24,500 | — | $0 | 245,883 | SEC↗ |
| RTRX Retrophin, Inc. | M Exercise deriv | 2018-03-07 | 2018-03-08 | 278 | — | $0 | 0 | SEC↗ |
| RTRX Retrophin, Inc. | M Exercise | 2018-03-07 | 2018-03-08 | 278 | $6.00 | $1.7K | 221,383 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2018-02-08 | 2018-02-12 | 3,549 | — | $0 | 221,105 | SEC↗ |
| RTRX Retrophin, Inc. | G Gift | 2017-12-26 | 2017-12-27 | 23,000 | — | $0 | 217,556 | SEC↗ |
| RTRX Retrophin, Inc. | G Gift | 2017-12-21 | 2017-12-27 | 5,000 | — | $0 | 240,556 | SEC↗ |
| ACER Acer Therapeutics Inc. | P Buy | 2017-12-14 | 2017-12-18 | 2,000 | $12.00 | $24.0K | 13,905 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2017-10-04 | 2017-10-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ACER Acer Therapeutics Inc. | J Other deriv | 2017-09-19 | 2017-09-21 | 21,000 | — | $0 | 21,000 | SEC↗ |
| ACER Acer Therapeutics Inc. | J Other | 2017-09-19 | 2017-09-21 | 11,905 | — | $0 | 11,905 | SEC↗ |
| RTRX Retrophin, Inc. | P Buy | 2017-06-14 | 2017-06-14 | 5,000 | $17.85 | $89.3K | 245,556 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2017-05-17 | 2017-05-18 | 165,000 | — | $0 | 165,000 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2016-11-22 | 2016-11-23 | 3,200 | $21.30 | $68.2K | 240,556 | SEC↗ |
| RTRX Retrophin, Inc. | G Gift | 2016-11-21 | 2016-11-23 | 57,000 | — | $0 | 248,756 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2016-11-21 | 2016-11-23 | 5,000 | $21.00 | $105.0K | 243,756 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2016-05-19 | 2016-05-23 | 160,000 | — | $0 | 160,000 | SEC↗ |
| RTRX Retrophin, Inc. | G Gift | 2016-01-27 | 2016-01-29 | 3,000 | — | $0 | 305,756 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2015-11-10 | 2015-11-12 | 30,000 | $18.72 | $561.6K | 308,756 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2015-11-09 | 2015-11-12 | 30,000 | $18.77 | $563.1K | 338,756 | SEC↗ |
| RTRX Retrophin, Inc. | G Gift | 2015-09-11 | 2015-09-15 | 3,000 | — | $0 | 368,756 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2015-07-01 | 2015-07-02 | 150,000 | — | $0 | 150,000 | SEC↗ |
| RTRX Retrophin, Inc. | P Buy | 2014-11-21 | 2014-11-21 | 8,700 | $8.50 | $74.0K | 371,756 | SEC↗ |
| RTRX Retrophin, Inc. | P Buy | 2014-11-20 | 2014-11-21 | 1,300 | $8.20 | $10.7K | 363,056 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2014-11-06 | 2014-11-10 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2014-11-06 | 2014-11-10 | 100,000 | — | $0 | 361,756 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2014-05-28 | 2014-06-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2013-12-06 | 2013-12-27 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RTRX Retrophin, Inc. | P Buy deriv | 2013-08-15 | 2013-12-27 | 278 | — | $0 | 278 | SEC↗ |
| RTRX Retrophin, Inc. | P Buy | 2013-08-15 | 2013-12-27 | 556 | $4.50 | $2.5K | 261,756 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-07-02 | 2012-07-05 | 95,345 | $17.54 | $1.67M | 319,375 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-07-02 | 2012-07-05 | 95,345 | $17.54 | $1.67M | 154,375 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-07-02 | 2012-07-05 | 95,345 | $40.00 | $3.81M | 59,030 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-15 | 2012-05-17 | 10,000 | $17.33 | $173.3K | 414,720 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-15 | 2012-05-17 | 10,000 | $17.33 | $173.3K | 69,030 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-05-15 | 2012-05-17 | 10,000 | $38.64 | $386.4K | 59,030 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-11 | 2012-05-15 | 4,655 | $17.54 | $81.6K | 424,720 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise deriv | 2012-05-11 | 2012-05-15 | 16,875 | — | $0 | 429,375 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-11 | 2012-05-15 | 4,655 | $17.54 | $81.6K | 68,340 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-05-11 | 2012-05-15 | 4,655 | $37.98 | $176.8K | 63,685 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-05-11 | 2012-05-15 | 4,630 | $37.07 | $171.6K | 59,030 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | S Sale | 2012-05-11 | 2012-05-15 | 16,875 | $37.98 | $640.9K | 63,685 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | M Exercise | 2012-05-11 | 2012-05-15 | 16,875 | $14.39 | $242.8K | 80,560 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2012-05-08 | 2012-05-10 | 40,000 | — | $0 | 446,250 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-05-08 | 2012-05-10 | 16,000 | — | $0 | 63,685 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2012-04-30 | 2012-05-10 | 1,006 | $19.35 | $19.5K | 47,685 | SEC↗ |